Search results
Bryhali dosage: Form, strength, how to use, and more
Medical News Today· 4 days agoBryhali (halobetasol) is a brand-name drug prescribed to treat plaque psoriasis in adults. Bryhali belongs to a drug class called corticosteroids. Note:...
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena via Yahoo Finance· 6 days agoLEO Pharma has announced positive data from the Phase III clinical trial of Enstilar (LEO 90100) in...
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 7 days agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
Amgen Inc. (AMGN) To Go Ex-Dividend on May 16th
ETF DAILY NEWS· 12 hours agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) announced a quarterly dividend on Wednesday, March 6th, RTT News reports. This represents a $9.00 annualized dividend and a dividend yield of 2.92% ...
Blockbuster Drug Patent Thickets Signal 'Strategic Behavior'
MedPage Today· 2 days agoAn analysis of patent applications for 10 top-selling prescription drugs found that nearly...
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 7 days agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...
It Took Me Years to Find the Right Psoriatic Arthritis Medication
Verywell Health via Yahoo News· 5 hours agoAfter being diagnosed with psoriatic arthritis in 2016, it took LB Herbert years to find a psoriatic...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 4 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
5 Best Undervalued Stocks To Buy In May 2024
Forbes· 6 days agoResearching undervalued stocks? We examined stocks to identify the top undervalued stocks in May 2024. Dive into the results here.
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 3 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat ...